Skip to main content

Updated Clinical Practice Guidelines Available Online

Date:
October 24, 2019

To: All Providers

The following Clinical Practice Guidelines have been reviewed and approved by our Quality Management Committee (QMC) and can be viewed online at  bcbswny.com/provider > Policies & Guidelines > Practice Guidelines.

New guideline added:

Dementia - The American College of Physicians and American Academy of Family Physicians developed this guideline to present the available evidence on current pharmacologic treatment of dementia. https://www.aafp.org/dam/AAFP/documents/patient_care/clinical_recommendations/Dementia-Clinical-Practice-Guideline.pdf

The targeted literature search included evidence related to the effectiveness of five U.S. Food and Drug Administration approved pharmacologic therapies for dementia for outcomes in the domains of cognition, global function, behavior/mood, and quality of life/activities of daily living.

Recommendations:

1.    Clinicians should base the decision to initiate a trial of therapy with a cholinesterase inhibitor or memantine on individualized assessment. (Grade: weak recommendation, moderate-quality evidence.)

2.    Clinicians should base the choice of pharmacologic agents on tolerability, adverse effect profile, ease of use, and cost of medication. The evidence is insufficient to compare the effectiveness of different pharmacologic agents for the treatment of dementia. (Grade: weak recommendation, low-quality evidence.)

3.    There is an urgent need for further research on the clinical effectiveness of pharmacologic management of dementia.

Guidelines with no content changes:

  • Asthma
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Cardiovascular Disease (Atrial Fibrillation; Cholesterol/CAD; Risk Assessment and Primary Prevention; Hypertension; Heart Failure; and Stroke)
  • Chronic Kidney Disease (CKD)
  • Depression
  • Diabetes
  • Falls Prevention
  • Hip and Knee
  • HIV/AIDS
  • Obesity
  • Obstructive Sleep Apnea (OSA)
  • Palliative Care
  • Right Start Maternity/Prenatal
  • Sexually Transmitted Diseases (STDs)
  • Spine
  • Substance Use Disorder
  • Tobacco Cessation

Guidelines with content changes:

  • Chronic Obstructive Pulmonary Disease (COPD)
    • Initial treatment (based on the ABCD Assessment Tool) was separated from follow-up treatment.
    • Blood eosinophil count added as a biomarker for estimating the efficacy of inhaled corticosteroids for the prevention of exacerbations.
  • Stroke
    • Moved under Cardiovascular Disease section

Updated preventive health guidelines are also available for:

  • Adolescents (birth to 18 years)
  • Adult (men and women)
  • Immunizations (childhood and adult)

To request a paper copy, please call 1-877-878-8785, option 2. Leave your name, address, and the specific guideline you are requesting.

Recent Articles

  • Individual Provider Recontracting Initiative
    We will be amending and restating our existing contracts. Starting next month, all directly contracted individual providers will be sent an updated contract. The New York State Department of Health (DOH) requires that each provider sign and return their amended/restated contract.
  • New Digital Provider and Facility Reference Manual
    We’ve upgraded our Provider and Facility Reference Manual, which is now available in digital format. The new manual offers a better, more interactive user experience. Here, we highlight some of the new features.
  • Updates to Screening for Hepatitis C Virus (HCV) in Adults
    Hepatitis C virus (HCV) is reportedly the most common blood infection in the country. The U.S. Preventive Services Task Force has updated the recommendation for HCV screening in March 2020 to now include all adults ages 18 to 79 without known liver disease, regardless of their risk for infection.
  • Update to Spine Preauthorization Process
    To help streamline the preauthorization process for spine procedures and injections, all these requests will be submitted directly to our Utilization Management Department beginning October 1, 2020. We will no longer require any requests to be submitted through Palladian Health.
  • Care at Home Expanded for Medicare Advantage Patients
    Beginning on July 7, more Medicare Advantage patients will be eligible to enroll in a new extension of the Care at Home program -- Care at Home℠ On Call -- which offers some urgent care in-home services. Care at Home On Call will be offered to newly enrolled Medicare Advantage members.

Working with Us

Additional Resources

We want to hear from you! Have a topic request for the next Blue Bulletin? Email us

Stay in Touch! Sign up to receive emails for provider news and information